April 2026 The European Chemicals Agency (ECHA) updated regulatory information concerning salicylic acid under the REACH Regulation, including revisions to harmonized classification and labeling guidance for manufacturers and downstream users within the European Union.
February 2026 SEQENS highlighted expanded production capabilities for pharmaceutical active ingredients (APIs) and specialty ingredients, including salicylic acid derivatives, at its European manufacturing sites as part of its pharmaceutical manufacturing strategy.
September 29, 2025: Aurorium announced the expansion of its benzene derivatives portfolio, including pharmaceutical and specialty chemical intermediates used in the production of salicylic acid and related compounds. The expansion was aimed at strengthening supply reliability for pharmaceutical and personal care manufacturers.